9-Sep-2026
DLH to Provide Mission-Critical Cyber Support for U.S. Navy
Globe Newswire (Tue, 18-Aug 9:26 AM ET)
DLH Reports Fiscal 2026 Third Quarter Results
Globe Newswire (Wed, 29-Jul 4:15 PM ET)
DLH to Announce Fiscal 2026 Third Quarter Financial Results
Globe Newswire (Mon, 20-Jul 8:00 AM ET)
DLH Announces Leadership Transition
Globe Newswire (Tue, 30-Jun 4:15 PM ET)
DLH Lands $250M U.S. Navy Contract, Unlocking New Growth Channels in Federal IT Services
Market Chameleon (Fri, 26-Jun 3:06 AM ET)
DLH Contract Award Opens New Growth Channels with U.S Navy
Globe Newswire (Thu, 25-Jun 4:07 PM ET)
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.
DLH Holdings Corp. trades on the NASDAQ stock market under the symbol DLHC.
As of September 9, 2026, DLHC stock price declined to $3.82 with 10,666 million shares trading.
DLHC has a beta of 0.52, meaning it tends to be less sensitive to market movements. DLHC has a correlation of 0.05 to the broad based SPY ETF.
DLHC has a market cap of $55.36 million. This is considered a Micro Cap stock.
Last quarter DLH Holdings Corp. reported $44 million in Revenue and -$1.16 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$.99.
In the last 3 years, DLHC traded as high as $17.58 and as low as $2.72.
The top ETF exchange traded funds that DLHC belongs to (by Net Assets): VTI, VXF, DFAT, DFAS, DFMC.
DLHC has underperformed the market in the last year with a price return of -33.7% while the SPY ETF gained +18.7%. DLHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.4% and -15.2%, respectively, while the SPY returned +3.4% and -0.5%, respectively.
DLHC support price is $3.83 and resistance is $4.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DLHC shares will trade within this expected range on the day.